Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Quotient Ltd Ord (QTNT)

Quotient Ltd Ord (QTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 981
  • Shares Outstanding, K 2,580
  • Annual Sales, $ 38,510 K
  • Annual Income, $ -125,130 K
  • 60-Month Beta 2.20
  • Price/Sales 0.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade QTNT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -53.21
  • Most Recent Earnings $-10.81 on 11/14/22
  • Latest Earnings Date 02/14/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -4.40
  • Number of Estimates 1
  • High Estimate -4.40
  • Low Estimate -4.40
  • Prior Year -17.60
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1811 +109.83%
on 12/23/22
0.8337 -54.42%
on 12/01/22
-0.3800 (-50.00%)
since 11/30/22
3-Month
0.1811 +109.83%
on 12/23/22
7.0400 -94.60%
on 10/05/22
-5.6200 (-93.67%)
since 09/30/22
52-Week
0.1811 +109.83%
on 12/23/22
105.2000 -99.64%
on 12/31/21
-96.4200 (-99.61%)
since 12/30/21

Most Recent Stories

More News
Nemaura Medical, Inc. (NMRD) Reports Q2 Loss, Misses Revenue Estimates

Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of 0% and 75.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

NMRD : 0.0890 (+11.11%)
QTNT : 0.3800 (+2.73%)
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 9.09% and 0.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MASS : 7.55 (+8.63%)
QTNT : 0.3800 (+2.73%)
Paragon 28, Inc. (FNA) Reports Q3 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of 0% and 8.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

FNA : 12.35 (+3.69%)
QTNT : 0.3800 (+2.73%)
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 21.43% and 9.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

TMCI : 13.05 (+5.58%)
QTNT : 0.3800 (+2.73%)
Artivion (AORT) Reports Q3 Loss, Tops Revenue Estimates

Artivion (AORT) delivered earnings and revenue surprises of 54.55% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AORT : 21.16 (-2.17%)
QTNT : 0.3800 (+2.73%)
Hologic (HOLX) Beats Q4 Earnings and Revenue Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 32.26% and 9.98%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HOLX : 77.96 (+0.79%)
QTNT : 0.3800 (+2.73%)
Sannova Appoints Jason Apter as CEO and Stephen Unger as CFO

Sannova Analytical, LLC (“Sannova”), a leading contract research organization (“CRO”) that provides bioanalytical testing and analytical chemistry services to innovative pharmaceutical and biotechnology...

QTNT : 0.3800 (+2.73%)
Quotient (QTNT) Reports Q1 Loss, Lags Revenue Estimates

Quotient (QTNT) delivered earnings and revenue surprises of -32.14% and 6.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

QTNT : 0.3800 (+2.73%)
SGHT : 5.28 (+1.93%)
Shockwave Medical (SWAV) Reports Next Week: Wall Street Expects Earnings Growth

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SWAV : 325.63 (+0.94%)
QTNT : 0.3800 (+2.73%)
Analysts Estimate Quotient (QTNT) to Report a Decline in Earnings: What to Look Out for

Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QTNT : 0.3800 (+2.73%)
IDXX : 539.93 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania....

See More

Key Turning Points

3rd Resistance Point 0.6267
2nd Resistance Point 0.5533
1st Resistance Point 0.4667
Last Price 0.3800
1st Support Level 0.3067
2nd Support Level 0.2333
3rd Support Level 0.1467

See More

52-Week High 105.2000
Fibonacci 61.8% 65.0828
Fibonacci 50% 52.6906
Fibonacci 38.2% 40.2983
Last Price 0.3800
52-Week Low 0.1811

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar